In the Journals

Tofacitinib linked to 2-fold greater risk for herpes zoster in RA

January 27, 2020
Among patients with rheumatoid arthritis, tofacitinib is associated with a 2-fold greater risk for herpes zoster infection compared with etanercept…

In the Journals

Less than 40% of patients with high RA disease activity modify treatment

January 23, 2020
Despite treat-to-target recommendations for rheumatoid arthritis, only 38% of patients with high disease activity were offered a treatment change…

Education Lab

Ace the Case: A 63-Year-Old Man With a 1-Week History of Headache and Neck Pain

Healio Rheumatology, January 2020
Learning Objective: Upon successful completion of this educational activity, participants should be better able to identify patients with crowned…

In the Journals

Mental distress highly prevalent among adults with arthritis in Appalachia, southern US

January 16, 2020
Frequent mental distress is commonly reported among adults with arthritis across all 50 states and Washington, D.C., with the highest prevalence…

In the Journals

Smoking, greater disease activity leading predictors of muscle density declines in RA

January 15, 2020
Declines in muscle density among patients with rheumatoid arthritis are linked to greater disease activity, smoking and low insulin-like growth…

In the Journals

Hospital culture, cost pressures influence divergent anti-TNF prescribing decisions in RA

January 14, 2020
Factors that impact TNF inhibitor prescribing decisions for patients with rheumatoid arthritis can range from cost pressures, to the pharmaceutical…

In the Journals

Multimorbidity accumulation in RA accounts for excess mortality

January 8, 2020
The accumulation of multimorbidity following a rheumatoid arthritis diagnosis can account for excess total and cardiovascular mortality among women…

In the JournalsPerspective

Biosimilar cost savings offsets expense incurred by higher infliximab doses

January 2, 2020
Although infliximab doses can frequently increase threefold or more for patients with rheumatoid arthritis, the savings from the current price of its…

In the JournalsPerspective

All biologics increase risk for tuberculosis

December 31, 2019
Among patients with rheumatic diseases, treatment with any biologic increases the risk for tuberculosis, both reactivation and new-onset, with an…

In the Journals

Upadacitinib improves health-related QoL in difficult-to-treat RA

December 27, 2019
Among those with rheumatoid arthritis who previously had an inadequate response to biologic DMARDs, upadacitinib, in doses of either 15 mg or 30 mg…

Celebrating the life of Calvin R. Brown, Jr., MD, rheumatologist and teacher

December 20, 2019
The rheumatology community lost clinician and educator Calvin R. Brown, MD, on Dec. 1, 2019. He was 66 years old. His final years were spent at the…

In the JournalsPerspective

ACR permits use of multibiomarker disease activity score in updated RA recommendations

December 19, 2019
The 2019 update of the American College of Rheumatology recommended rheumatoid arthritis disease activity measures now includes a stipulation to…

In the JournalsPerspective

9/11 first responders at increased risk for systemic autoimmune disease

December 18, 2019
Intense dust cloud inhalation, as well as PTSD, experienced by first responders and community members present at the Sept. 11 terrorist attack in New…

In the Journals

High-dose trivalent flu vaccine safe, more immunogenic than standard dose in RA

December 17, 2019
Among patients with seropositive rheumatoid arthritis, high-dose trivalent inactivated influenza vaccines are safe and more immunogenic than the…

In the JournalsPerspective

Cancer risk slightly higher among patients treated with abatacept

December 17, 2019
Although the risks for specific cancers and infections were similar between abatacept and other biologic and targeted synthetic DMARDs among patients…

In the Journals

Intersectional inequalities persist for OA, RA, gout diagnosis, not SpA

December 16, 2019
Although there are considerable intersectional inequalities among various age, gender and socioeconomic groups in the likelihood of diagnosis for…

Feature

The Not So Golden Age of Rheumatology Therapy

December 13, 2019
Treatment options for rheumatoid arthritis have changed drastically over the past 30 years, but some of today’s rheumatologists can still…

In the Journals

Asthma linked to elevated anti-citrullinated antibodies in rheumatoid arthritis

December 12, 2019
A strong association was observed between asthma and anti-citrullinated antibody elevation in a cohort of women with rheumatoid arthritis, and this…

Health officials issue safety alert on unapproved stem cell products after Nebraska outbreak

December 10, 2019
Officials from the Nebraska Department of Health and Human Services have issued a public health advisory following multiple reports of serious…

In the Journals

Innovative clinical trial designs, therapies for refractory disease top unmet needs in rheumatology

December 10, 2019
New treatments and trial designs, particularly focused on patients with refractory disease, remain among the top unmet needs in rheumatology in 2019…